臺灣核心實作指引(TW Core IG)
0.3.2 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example MedicationDispense: 鹽酸四環素眼藥膏藥品配藥資料

鹽酸四環素眼藥膏藥品配藥資料

配藥的狀態：Completed ( MedicationDispense Status Codes#completed)

配藥的分類： Inpatient ( MedicationDispense Category Codes#inpatient)

配藥的類型：Daily Fill ( V3 Value SetActPharmacySupplyType#DF)

藥品：鹽酸四環素眼藥膏 ( 臺灣藥品許可證#內衛藥製字第006008號)

病人：Patient/pat-example "陳加玲"

就醫資料：Encounter/enc-example

配藥者：Practitioner/pra-phc-example "陳耀詩"

配藥資料：

藥品總劑量：1 Topical Cream ( OrderableDrugForm#TOPCRM)
藥品天數：7 days
藥品使用方法：每天早晚擦拭傷口處
藥品包裝和審核時間：2022-08-01T09:30:00
藥品發放的時間：2022-08-01T10:00:00

藥品替代資料：

配藥是否與處方要求不同：none ( SubstanceAdminSubstitution#N)
替代原因：formulary policy ( ActReason#FP)